Sex male/female | N (% of all) | Age [a] | Prothrombin time [%] | ISS | NISS | APACHE II | |
---|---|---|---|---|---|---|---|
Death day 0 | 50/24 | 74 (9.6%) | 47.5 (18–89, 47.7, ± 19.7) | 37 (10–100, 42.1, ± 22.4) | 41.0 (18–75, 40.3, ± 13.6) | 50.0 (20–75, 52.0, ± 15.2) | 30.0 (9–43, 29.0, ± 7.9) |
Death day 1-3 | 138/46 | 184 (23.9%) | 42.5 (17–89, 45.5, ± 19.2) | 56 (10–100, 58.9, ± 23.6) | 34.0 (17–75, 37.8, ± 13.4) | 50.0 (20–77, 50.2, ± 14.1) | 25.0 (6–44, 25.5, ± 7.6) |
Survival day > 3 | 385/127 | 512 (66.5%) | 36.5 (16–88, 39.1, ± 16.6) | 84 (14–121, 80.5, ± 19.3) | 29.0 (17–75, 32.6, ± 11.9) | 41.0 (29–75, 41.2, ± 13.4) | 15.0 (0–40, 15.2, ± 7.9) |
All | 573/197 | 770 | 38.5 (16–89, 41.4, ± 17.9) | 78 (10–121, 73.7, ± 23.5) | 33.0 (17–75, 34.6, ± 12.8) | 43.0 (17–77, 44.4, ± 14.5) | 19.0 (0–44, 18.9, ± 9.5) |